Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine with TAP block for postoperative delirium in elderly abdominal surgery
ChiCTR2500108562Phase 4Not yet recruiting
- Sponsor
- Liupanshui People's Hospital
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in postoperative delirium (POD) and postoperative pain (3 arms), sponsored by Liupanshui People's Hospital. Primary endpoint: Incidence of postoperative delirium within 5 days. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative delirium (POD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2500108562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108562.